These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Splicing Factor Mutations in Cancer. Bejar R Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388 [TBL] [Abstract][Full Text] [Related]
10. Pan-cancer analysis identifies mutations in Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164 [TBL] [Abstract][Full Text] [Related]
11. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms. Brierley CK; Steensma DP Curr Hematol Malig Rep; 2016 Dec; 11(6):408-415. PubMed ID: 27492253 [TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts. Kang MG; Kim HR; Seo BY; Lee JH; Choi SY; Kim SH; Shin JH; Suh SP; Ahn JS; Shin MG BMC Cancer; 2015 Jun; 15():484. PubMed ID: 26115659 [TBL] [Abstract][Full Text] [Related]
13. Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia. Shiozawa Y; Malcovati L; Gallì A; Sato-Otsubo A; Kataoka K; Sato Y; Watatani Y; Suzuki H; Yoshizato T; Yoshida K; Sanada M; Makishima H; Shiraishi Y; Chiba K; Hellström-Lindberg E; Miyano S; Ogawa S; Cazzola M Nat Commun; 2018 Sep; 9(1):3649. PubMed ID: 30194306 [TBL] [Abstract][Full Text] [Related]
14. Spliceosomal factor mutations and mis-splicing in MDS. Hershberger CE; Daniels NJ; Padgett RA Best Pract Res Clin Haematol; 2020 Sep; 33(3):101199. PubMed ID: 33038983 [TBL] [Abstract][Full Text] [Related]
15. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer. Zhang J; Huang J; Xu K; Xing P; Huang Y; Liu Z; Tong L; Manley JL Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2216712119. PubMed ID: 36459648 [No Abstract] [Full Text] [Related]
16. [Role of Aberrant Splicing in Pathogenesis of Myelodysplastic Syndromes-Review]. Li L; Xiao ZJ; Sun XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):617-621. PubMed ID: 28446323 [TBL] [Abstract][Full Text] [Related]
17. Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes. Nguyen HD; Leong WY; Li W; Reddy PNG; Sullivan JD; Walter MJ; Zou L; Graubert TA Cancer Res; 2018 Sep; 78(18):5363-5374. PubMed ID: 30054334 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation. Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the SF3B1-SUGP1 interface reveals how numerous cancer mutations cause mRNA missplicing. Zhang J; Xie J; Huang J; Liu X; Xu R; Tholen J; Galej WP; Tong L; Manley JL; Liu Z Genes Dev; 2023 Dec; 37(21-24):968-983. PubMed ID: 37977822 [TBL] [Abstract][Full Text] [Related]
20. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast. Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]